Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
absolute, accretion, Boston, CardiAQ, Chancery, ClearSight, collaborate, Commander, complaint, contrary, Czech, deficiency, degenerative, destruction, dividend, Division, dysfunction, elderly, encouraging, EP, exhausted, flat, FloTrac, Fogarty, foreseeable, GmbH, Harpoon, imaging, ineffective, infrastructure, intervention, Justice, leaflet, left, LivaNova, LLC, loop, meaningful, mechanical, Medizintechnik, newly, noncurrent, ordinary, passage, Prague, PreSep, privacy, proactive, prosthetic, provisional, PVT, reclassification, regurgitation, relief, RESILIA, resume, revalue, SA, Sadra, Scimed, sealing, Shanghai, shock, signify, split, strain, therapeutic, THV, TMVR, tricuspid, type, unobservable, unspecified, upgrade, ventricular, weighted
Removed:
BMEYE, byoperating, CENTERA, circulatory, cohort, commercialization, deploy, disposed, embolic, enrollment, force, GPO, implanting, incision, informed, inInternal, ininvesting, inoperable, intricate, intuitive, legislative, millionincrease, minimal, ofPERIMOUNT, output, physiologic, profitable, quicker, reclassed, reinstated, repositionable, scarring, Sorin, sublicense, suturing, TAVR, temporary, theMagna, thePreSep, theSAPIEN, transferred, TRANSFORM, volumetric
Filing tables
Filing exhibits
Related press release
EW similar filings
Filing view
External links
Exhibit 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (Nos. 333-33054, 333-33056, 333-40434, 333-52332, 333-52334, 333-52346, 333-60670, 333-98219, 333-105961, 333-127260, 333-150810, 333-154242, 333-168462, 333-183106, 333-192229, 333-195853, and 333-204180) of Edwards Lifesciences Corporation of our report dated February 19, 2016 relating to the consolidated financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Irvine, California
February 19, 2016